TweenVax
Published in academic literature
App Summary
App Screenshots















Detailed Description
Functionality & Mechanism
TweenVax is an intervention designed to promote adolescent vaccination by providing parents with clear, reliable information about recommended vaccines for 11–12 year olds, specifically HPV, meningococcal, and Tdap. Developed by researchers at the University of Tennessee Health Science Center and Emory University, the app educates users on vaccine importance, timing, and protective benefits.
Evidence & Research Context
- A clinical trial is underway to compare the effect of the TweenVax intervention against standard-of-care vaccination promotion practices on human papillomavirus (HPV) vaccination rates in adolescents.
- The TweenVax intervention is comprehensive, targeting practice, provider, and parent/patient levels.
- The study is being delivered across sites in Georgia and Tennessee.
- The primary objective of the trial is to improve adolescent HPV vaccine uptake.
- This research is documented in academic literature.
Intended Use & Scope
TweenVax is intended for parents seeking information on adolescent vaccines to protect their children from serious diseases. The app focuses on HPV, meningococcal, and Tdap vaccines. It serves as an informational resource and does not provide medical advice or replace consultation with a healthcare professional. Users should seek further guidance from their child's doctor for personalized medical recommendations.
Studies & Publications
Peer-reviewed research associated with this app.
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
Bednarczyk et al. (2025)
Registered trial of TweenVaxApp Information
Developer
Emory UniversityCategory
Evidence Profile
Published in academic literature
Platforms
Updated
Oct 2025
© 2025 Emory University